A Study of MG7 Redirected Autologous T Cells for Advanced MG7 Positive Liver Metastases(MG7-CART)

Clinical trial NCT02862704 · UNKNOWN

Trial details

NCT number: NCT02862704
Sponsor: Xijing Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Liver Metastases

Start date: 2016-06-01
Primary completion: 2017-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.